New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
Key claim: The FDA is amending the animal drug regulations to reflect new animal drug application (NADA), abbreviated NADA, and conditionally approved NADA actions from January–March 2026 and to improve regulatory accuracy and readability.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), and conditionally approved new animal drug applications (CNADAs) during January, February, and March 2026. The animal drug regulations are also being amended to improve their accuracy and readability.
Why this matters
The FDA is amending the animal drug regulations to reflect new animal drug application (NADA), abbreviated NADA, and conditionally approved NADA actions from January–March 2026 and to improve regulatory accuracy and readability.